These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36639983)

  • 1. Bioresponsive Immunotherapeutic Materials.
    Han J; Sheng T; Zhang Y; Cheng H; Gao J; Yu J; Gu Z
    Adv Mater; 2023 Jan; ():e2209778. PubMed ID: 36639983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy.
    Shang Q; Dong Y; Su Y; Leslie F; Sun M; Wang F
    Adv Drug Deliv Rev; 2022 Jun; 185():114308. PubMed ID: 35472398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioresponsive drug delivery systems for the treatment of inflammatory diseases.
    Dou Y; Li C; Li L; Guo J; Zhang J
    J Control Release; 2020 Nov; 327():641-666. PubMed ID: 32911014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of immunotherapeutics for enhanced cancer immunotherapy after local delivery.
    Jin Q; Liu Z; Chen Q
    J Control Release; 2021 Jan; 329():882-893. PubMed ID: 33053396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances of bioresponsive polymeric nanomedicine for cancer therapy.
    Hong T; Shen X; Syeda MZ; Zhang Y; Sheng H; Zhou Y; Xu J; Zhu C; Li H; Gu Z; Tang L
    Nano Res; 2023; 16(2):2660-2671. PubMed ID: 36405982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Stimuli-Responsive Platforms for Cancer Immunotherapy.
    Li L; Yang Z; Chen X
    Acc Chem Res; 2020 Oct; 53(10):2044-2054. PubMed ID: 32877161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switchable Dual-Function and Bioresponsive Materials to Control Bacterial Infections.
    Ghasemlou M; Daver F; Ivanova EP; Rhim JW; Adhikari B
    ACS Appl Mater Interfaces; 2019 Jul; 11(26):22897-22914. PubMed ID: 31180196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioresponsive functional nanogels as an emerging platform for cancer therapy.
    Huang D; Qian H; Qiao H; Chen W; Feijen J; Zhong Z
    Expert Opin Drug Deliv; 2018 Jul; 15(7):703-716. PubMed ID: 29976103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heading toward Macromolecular and Nanosized Bioresponsive MRI Probes for Successful Functional Imaging.
    Angelovski G
    Acc Chem Res; 2017 Sep; 50(9):2215-2224. PubMed ID: 28841293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
    Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
    J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioresponsive Nanomedicine: The Next Step of Deadliest Cancers' Theranostics.
    Mao Y; Liu X
    Front Chem; 2020; 8():257. PubMed ID: 32328480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy.
    Zhou L; Zhang P; Wang H; Wang D; Li Y
    Acc Chem Res; 2020 Sep; 53(9):1761-1772. PubMed ID: 32819102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade.
    Yu S; Wang C; Yu J; Wang J; Lu Y; Zhang Y; Zhang X; Hu Q; Sun W; He C; Chen X; Gu Z
    Adv Mater; 2018 Jul; 30(28):e1801527. PubMed ID: 29786888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.
    Gou S; Huang Y; Wan Y; Ma Y; Zhou X; Tong X; Huang J; Kang Y; Pan G; Dai F; Xiao B
    Biomaterials; 2019 Aug; 212():39-54. PubMed ID: 31103945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering vaccines and niches for immune modulation.
    Purwada A; Roy K; Singh A
    Acta Biomater; 2014 Apr; 10(4):1728-40. PubMed ID: 24373907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatorial drug delivery approaches for immunomodulation.
    Stewart JM; Keselowsky BG
    Adv Drug Deliv Rev; 2017 May; 114():161-174. PubMed ID: 28532690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Status and Future Directions of Nanoparticulate Strategy for Cancer Immunotherapy.
    Zhou X; Liu R; Qin S; Yu R; Fu Y
    Curr Drug Metab; 2016; 17(8):755-762. PubMed ID: 27411558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Stepwise Extraction" strategy-based injectable bioresponsive composite implant for cancer theranostics.
    Yang B; Lin H; Dai C; Chen Y; Shi J
    Biomaterials; 2018 Jun; 166():38-51. PubMed ID: 29533789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioresponsive DNA Hydrogels: Beyond the Conventional Stimuli Responsiveness.
    Wang D; Hu Y; Liu P; Luo D
    Acc Chem Res; 2017 Apr; 50(4):733-739. PubMed ID: 28186723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.